Dr. Guerriero is Awarded a Terri Brodeur Breast Cancer Fellowship
January 1, 2020
Modulating the immune system as an anti-cancer strategy has shown great promise in some types of cancer, however there has…
Drs. Shapiro and Guerriero Publish Key Findings on the Role of PARP Inhibitors in TNBC
July 28, 2019
This work demonstrates cross-talk between PARP inhibition and the tumor microenvironment related to STING/TBK1/IRF3 pathway activation in cancer cells that…